'Then her neighbour will not know her status': how health providers advocate antiretroviral therapy under universal test and treat.


Journal

International health
ISSN: 1876-3405
Titre abrégé: Int Health
Pays: England
ID NLM: 101517095

Informations de publication

Date de publication:
01 01 2019
Historique:
received: 14 02 2018
accepted: 10 07 2018
pubmed: 24 8 2018
medline: 14 6 2019
entrez: 24 8 2018
Statut: ppublish

Résumé

Universal test and treat (UTT)-antiretroviral therapy (ART) for all HIV-positive individuals regardless of CD4 count-is the WHO's recommended treatment guideline. UTT has implications for health providers' workload in areas of high HIV prevalence and for understandings of ART and HIV. This article explores health providers' experiences of implementing UTT in Hhohho Region, Eswatini. Between March 2015 and October 2016, in-depth interviews were conducted with health providers implementing UTT. Interviews were transcribed verbatim and translated into English for qualitative content analysis. Twenty-five providers from eight facilities were interviewed. Respondents encouraged early ART by promoting its overall health benefits, and the possibility of avoiding disclosure and HIV-related stigma in the community. Some health providers downplayed UTT's preventive benefits to avoid discouraging condom use. Respondents suggested that initiating ART immediately after testing could improve linkage-to-care, but recognized that overly hasty initiation might affect adherence. Viral load testing was seen as a potentially useful tool to monitor clients' response to ART. Health providers appropriated stigma to encourage early ART. This suggests an attentiveness to the social burden of HIV/AIDS, but potentially exacerbates discrimination and conflicts with efforts to reduce HIV-related stigma.

Identifiants

pubmed: 30137387
pii: 5076194
doi: 10.1093/inthealth/ihy058
doi:

Substances chimiques

Anti-Retroviral Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

36-41

Auteurs

Christopher Pell (C)

Amsterdam Institute for Social Science Research, University of Amsterdam, Nieuwe Achtergracht 166, WV, Amsterdam, the Netherlands.
Amsterdam Institute for Global Health and Development (AIGHD), AHTC, Tower C4, Paasheuvelweg 25, BP, Amsterdam, the Netherlands.

Ria Reis (R)

Amsterdam Institute for Social Science Research, University of Amsterdam, Nieuwe Achtergracht 166, WV, Amsterdam, the Netherlands.
The Children's Institute, School of Child and Adolescent Health, University of Cape Town, 46 Sawkins Road, Rondebosch, Cape Town, South Africa.
Department of Public Health and Primary Care, Leiden University Medical Centre, Hippocratespad 21 ZD, Leiden, the Netherlands.

Njabuliso Dlamini (N)

Amsterdam Institute for Social Science Research, University of Amsterdam, Nieuwe Achtergracht 166, WV, Amsterdam, the Netherlands.
Clinton Health Access Initiative, 4th Floor, Lilunga House, Somhlolo Road, Mbabane, Eswatini.

Eileen Moyer (E)

Amsterdam Institute for Social Science Research, University of Amsterdam, Nieuwe Achtergracht 166, WV, Amsterdam, the Netherlands.

Eva Vernooij (E)

Amsterdam Institute for Social Science Research, University of Amsterdam, Nieuwe Achtergracht 166, WV, Amsterdam, the Netherlands.
Department of Social Anthropology, School of Social and Political Science, University of Edinburgh, Edinburgh, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH